3C-E Facts
Psychedelic;
Description
3C-E (3,5-dimethoxy-4-ethoxyamphetamine) is a synthetic psychedelic of the phenethylamine class. It activates serotonin receptors in the brain,[1] producing the visual and cognitive shifts characteristic of classical psychedelics.
Subjective effects include geometric visual patterns, color enhancement, closed-eye imagery, trembling, and generalized bodily heaviness. The experience is defined by the tension between rich, jewel-like visuals and a persistent physical burden — nausea, muscle tension, and somatic discomfort that dominates the session, especially at higher amounts.[2]
3C-E does not produce physical dependence, and no fatalities have been attributed to it — though this reflects its rarity, not established safety.[3] The central risk is a steep dose-response curve: modest dose increases sharply intensify both physical discomfort and psychological difficulty.[2]
Dose and durationby route · individual sensitivity varies
Starts in 30 – 120 minLasts 8 – 12 hoursAfter-effects 3 – 6 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Not assessed
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- LSD;
psilocybin; mescaline; DOx series; 2C-x series
Effectslikely at a common dose
- Perception
- Music enhancement;
Color enhancement; Visual drifting; Color alteration; Brightness alteration; Geometry; Visual breathing; +24 possible, including Spatial disorientation, Visual haze / noise, Vestibular distortion - Body
- Wakefulness;
Appetite suppression; Pupil dilation; Body high; Insomnia; +26 possible, including Nausea, Dehydration sensation, Heart rate perception changes - Thinking
- Conceptual thinking;
Thought connectivity; Novelty enhancement; Aesthetic enhancement; Openness enhancement; +21 possible, including Confusion, Suggestibility enhancement, Memory suppression - Feeling
- Emotional enhancement;
+7 possible, including Emotional lability, Anxiety, Paranoia - Self
- none likely · 8 possible, including Derealization
- Time
- Time alteration;
+2 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 3 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Halberstadt AL, Chatha M, Chapman SJ, Brandt SD (2019) Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice — Journal of Psychopharmacology doi:10.1177/0269881119826610
- [2]
- [3]^de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, Gonzalez-Maeso J (2022) Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice — ACS Chemical Neuroscience doi:10.1021/acschemneuro.2c00170